ZIOPHARM Oncology Inc (USD)
ZIOP
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range3.26 | 3.55
52-Wk Range- | -
Last Close3.37
Mkt Cap (m)722.14
Dividend yield-
ISINUS98973P1012
Volume2,192,704.00
Exchange VenueNAS

Company Profile

ZIOPHARM Oncology Inc is a biotechnology company which acquires, develops, and commercializes cancer therapies that can address unmet medical needs through synthetic biology.

Key Information
Price/Earning-
Price/Book4.00
Price/Sales-
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-130.47
Debt/Equity0.02

Documents

Prospectus
en 05/02/2020
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.ziopharm.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)1.374.336.866.390.150.00
Operating Income (m)-43.50-120.10-165.31-53.49-53.91-57.86
Net Income (m)-31.78-120.09-165.30-54.32-53.12-117.80
Basic EPS-0.31-0.96-1.32-0.530.96-0.70
Avg. Diluted Shares Outstanding (m)101.13125.42130.39136.94143.71167.95
Balance Sheet
USD201420152016201720182019
Current Assets (m)44.09152.52104.8890.7884.29105.49
Non Current Assets (m)1.151.201.4614.8210.773.62
Total Assets (m)45.24153.72106.35105.6195.05109.11
Current Liabilities (m)10.8318.1215.8120.869.4812.53
Total Liabilities (m)------
Total Equity (m)33.8487.3748.0247.1985.5695.01
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-36.65-0.01-58.33-54.67-49.46-40.85
Capital Expenditure (m)-0.19-0.41-0.55-0.74-0.46-0.28
Figures are quoted in USD unless stated otherwise
-
No change
$
3.37
Last Price